Poolbeg Pharma (POLB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

10.17p
   
  • Change Today:
    -0.033p
  • 52 Week High: 11.50
  • 52 Week Low: 6.55
  • Currency: UK Pounds
  • Shares Issued: 500.00m
  • Volume: 229,393
  • Market Cap: £50.83m

Poolbeg Pharma Overview

Poolbeg Pharma is a clinical stage infectious disease pharmaceutical company, with a capital light clinical model which the Directors believe enables it to develop multiple products faster and more cost effectively than the traditional biotech model. Poolbeg has aspirations to become the “one-stop shop” for Big Pharma seeking mid-stage products to license or acquire.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 2.8  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Poolbeg Pharma Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-21 n/a (2.34) (0.74)p n/a n/a n/a n/a 0.0%
31-Dec-22 n/a (4.78) (0.94)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Poolbeg Pharma Company Announcements

Director/PDMR Shareholding 22-Feb-2024 07:00 RNS
Director Share Purchase 19-Feb-2024 13:42 RNS
Board Role Change and Launch of EIP 15-Feb-2024 07:00 RNS

Poolbeg Pharma ShareCast News

Poolbeg Pharma to be granted US patent 20-Mar-2024 ShareCast
Director dealings: Poolbeg Pharma co-founder ups... 19-Feb-2024 ShareCast
Poolbeg upbeat on research into potential drug m... 12-Feb-2024 ShareCast

Latest Poolbeg Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Poolbeg Pharma Market Data

Currency UK Pounds
Share Price 10.17p
Change Today -0.033p
% Change -0.33 %
52 Week High 11.50
52 Week Low 6.55
Volume 229,393
Shares Issued 500.00m
Market Cap £50.83m

Poolbeg Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
60% below the market average60% below the market average60% below the market average60% below the market average60% below the market average
39.62% below the sector average39.62% below the sector average39.62% below the sector average39.62% below the sector average39.62% below the sector average
Price Trend
93.58% above the market average93.58% above the market average93.58% above the market average93.58% above the market average93.58% above the market average
96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average96.49% above the sector average
Income Not Available
Growth Not Available

Poolbeg Pharma Dividends

No dividends found

Trades for 23-Apr-2024

Time Volume / Share Price
12:23 2,000 @ 10.23p
12:22 11,718 @ 10.30p
12:22 12,000 @ 10.10p
12:19 586 @ 10.21p
12:07 48 @ 10.30p

Poolbeg Pharma Key Personnel

CEO Jeremy Skillington
CFO Ian O’Connel

Top of Page